PlainRecalls
FDA Devices Moderate Class II Terminated

DABRA Laser (RA-308 Excimer Laser) Intended Use: For use in ablating a channel in occlusive peripheral vascular disease. Indications: For crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease.

Reported: December 23, 2020 Initiated: October 16, 2020 #Z-0569-2021

Product Description

DABRA Laser (RA-308 Excimer Laser) Intended Use: For use in ablating a channel in occlusive peripheral vascular disease. Indications: For crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease.

Reason for Recall

Due to footswitch not meeting required specification for protection from ingress of solids or liquids. If spilling of liquids near or on the footswitch, it may fail in the 'on' position and allow the laser to continue to lase.

Details

Recalling Firm
Ra Medical Systems, Inc.
Units Affected
36 devices
Distribution
US Distribution to states of: AL, AZ, CA, FL, IL, IN, KY, LA, MD, NC, NV, NY, OK, OR, TX, and WA; and to OUS country: Japan.
Location
Carlsbad, CA

Frequently Asked Questions

What product was recalled?
DABRA Laser (RA-308 Excimer Laser) Intended Use: For use in ablating a channel in occlusive peripheral vascular disease. Indications: For crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease.. Recalled by Ra Medical Systems, Inc.. Units affected: 36 devices.
Why was this product recalled?
Due to footswitch not meeting required specification for protection from ingress of solids or liquids. If spilling of liquids near or on the footswitch, it may fail in the 'on' position and allow the laser to continue to lase.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 23, 2020. Severity: Moderate. Recall number: Z-0569-2021.